Germany · Delayed Price · Currency is EUR Aino Health AB Statistics
Total Valuation
Aino Health AB has a market cap or net worth of EUR 3.63 million. The enterprise value is 3.64 million.
| Market Cap | 3.63M |
| Enterprise Value | 3.64M |
Important Dates
The next estimated earnings date is Thursday, February 12, 2026.
| Earnings Date | Feb 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 204.57M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +41.55% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 16.50% |
| Owned by Institutions (%) | 21.07% |
| Float | 102.17M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.51 |
| PB Ratio | -14.31 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -6.83 |
| EV / Sales | 1.50 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.43
| Current Ratio | 0.43 |
| Quick Ratio | 0.43 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -32.59 |
Financial Efficiency
Return on equity (ROE) is -5,797.04% and return on invested capital (ROIC) is -523.25%.
| Return on Equity (ROE) | -5,797.04% |
| Return on Assets (ROA) | -37.85% |
| Return on Invested Capital (ROIC) | -523.25% |
| Return on Capital Employed (ROCE) | 253.74% |
| Revenue Per Employee | 127,036 |
| Profits Per Employee | -28,011 |
| Employee Count | 19 |
| Asset Turnover | 3.22 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -96.48% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -96.48% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.01 |
| Relative Strength Index (RSI) | 65.82 |
| Average Volume (20 Days) | 327 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Aino Health AB had revenue of EUR 2.41 million and -532,213 in losses. Loss per share was -0.00.
| Revenue | 2.41M |
| Gross Profit | 680,281 |
| Operating Income | -453,973 |
| Pretax Income | -532,213 |
| Net Income | -532,213 |
| EBITDA | -275,151 |
| EBIT | -453,973 |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 71,456 in cash and 74,984 in debt, giving a net cash position of -3,528.
| Cash & Cash Equivalents | 71,456 |
| Total Debt | 74,984 |
| Net Cash | -3,528 |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -253,895 |
| Book Value Per Share | -0.00 |
| Working Capital | -450,083 |
Cash Flow
| Operating Cash Flow | -125,003 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 28.18%, with operating and profit margins of -18.81% and -22.05%.
| Gross Margin | 28.18% |
| Operating Margin | -18.81% |
| Pretax Margin | -22.05% |
| Profit Margin | -22.05% |
| EBITDA Margin | -11.40% |
| EBIT Margin | -18.81% |
| FCF Margin | n/a |
Dividends & Yields
Aino Health AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -41.55% |
| Shareholder Yield | -41.55% |
| Earnings Yield | -14.65% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |